Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.
about
Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?Novel Molecular Markers for Breast CancerPrognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis.HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis.miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinomaMetronomic Cordycepin Therapy Prolongs Survival of Oral Cancer-Bearing Mice and Inhibits Epithelial-Mesenchymal Transition.HMGB1 attenuates TGF-β-induced epithelial-mesenchymal transition of FaDu hypopharyngeal carcinoma cells through regulation of RAGE expression.The multifaceted role of extracellular vesicles in metastasis: Priming the soil for seeding.DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells.The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer.EMT promoting transcription factors as prognostic markers in human breast cancer.Effect of selective small molecule inhibitors on MMP-9 and VEGFR-1 expression in p16-positive and -negative squamous cell carcinoma.Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.ERp29 inhibits tumorigenicity by suppressing epithelial mesenchymal transition in gastric cancer.MgCl2 and ZnCl2 promote human umbilical vein endothelial cell migration and invasion and stimulate epithelial-mesenchymal transition via the Wnt/β-catenin pathway.VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients.Clinicopathological and prognostic significance of Twist overexpression in NSCLC.Telocinobufagin inhibits the epithelial-mesenchymal transition of breast cancer cells through the phosphoinositide 3-kinase/protein kinase B/extracellular signal-regulated kinase/Snail signaling pathway.Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer.The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancerFGF9/FGFR2 increase cell proliferation by activating ERK1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells
P2860
Q26742115-18B21122-457C-4408-8F0B-8F760A4BE792Q26753160-B7EFFEB1-C538-4FD0-917C-4FC84239A41FQ36266501-97BA1129-BBC5-4CE3-8214-5415B8260DD5Q36543040-BB62AB6E-BCCB-4724-82F9-110C51AAF9A3Q37030764-032E28F2-62B7-419B-A307-D7E72BF8ED3CQ37225543-56386A24-D0B4-48ED-B0F6-BBC81B9053E8Q38707858-24C53E00-1EA3-40E9-BFDC-48C80C8899D4Q38712574-930C00E8-2588-4107-BFBD-49A3B7EF94C7Q38770064-17174B70-BAD2-487D-B3BE-546D06E68E37Q38783508-A55DC29E-5AA5-4E5F-A757-AE316F945337Q38880519-79311D93-61E5-4C9A-9961-BE37939D42CBQ38925675-8173C448-72BB-4281-910D-3C11B24DCCA5Q38965324-7B526835-62B0-4EF0-94F1-FD750E5EB149Q40196342-85990D2E-21C4-4E9F-AA10-A5E40B56809CQ42708335-5AAC080A-6448-43AF-B114-B11377B9247AQ47136458-B3075E7C-982B-4B03-9521-B67CFFEEA452Q47162605-9AF43DAF-1B30-4A0D-BF11-3B8DED6BD8F7Q48177300-7C86C6C8-AAF3-4A08-A593-E5D743B2307EQ52629163-4CE83FC5-A607-41A9-B6A4-A19B5CF7B0D9Q54112424-812D9FC2-ABC6-4B77-9F02-775B5ED542F1Q55070669-572EA914-4E0B-403F-A384-A4D6E9513335Q58579097-BE652B8A-EF68-406D-8D60-8C24044B26CAQ58713781-1D4AE3DE-ACAF-4E0B-B614-0C74A0C0407D
P2860
Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Over-Expressed Twist Associate ...... rs via ERK and Akt Activation.
@ast
Over-Expressed Twist Associate ...... rs via ERK and Akt Activation.
@en
type
label
Over-Expressed Twist Associate ...... rs via ERK and Akt Activation.
@ast
Over-Expressed Twist Associate ...... rs via ERK and Akt Activation.
@en
prefLabel
Over-Expressed Twist Associate ...... rs via ERK and Akt Activation.
@ast
Over-Expressed Twist Associate ...... rs via ERK and Akt Activation.
@en
P2093
P2860
P1433
P1476
Over-Expressed Twist Associate ...... rs via ERK and Akt Activation.
@en
P2093
Cai-Wen Du
Guo-Jun Zhang
Jing-Wen Bai
Wei-Ling Chen
Wen-He Huang
Xiao-Long Wei
Yong-Qu Zhang
Yuan-Ke Liang
P2860
P304
P356
10.1371/JOURNAL.PONE.0135851
P407
P577
2015-08-21T00:00:00Z